Evidence of widespread metabolite abnormalities in Myalgic encephalomyelitis/chronic fatigue syndrome: assessment with whole-brain magnetic resonance spectroscopy. — CFSMEATLAS
Evidence of widespread metabolite abnormalities in Myalgic encephalomyelitis/chronic fatigue syndrome: assessment with whole-brain magnetic resonance spectroscopy.
Mueller, Christina, Lin, Joanne C, Sheriff, Sulaiman et al. · Brain imaging and behavior · 2020 · DOI
Quick Summary
Researchers used advanced brain imaging to measure chemical substances in the brains of ME/CFS patients and compared them to healthy people. They found several differences in brain chemistry and temperature in ME/CFS patients, particularly in areas involved in processing pain and regulating energy. These changes suggest that inflammation in the brain may contribute to ME/CFS symptoms.
Why It Matters
This is the first whole-brain spectroscopy study in ME/CFS, providing broader evidence of neurochemical dysfunction beyond previously studied discrete regions. The findings support the neuroinflammation hypothesis of ME/CFS, potentially validating a biological basis for symptoms and opening avenues for targeted therapeutic interventions.
Observed Findings
Significantly elevated choline/creatine ratio in the left anterior cingulate cortex (p < 0.001) in ME/CFS patients compared to controls
Increased brain temperature in multiple regions (right insula, putamen, frontal cortex, thalamus, cerebellum) not explained by increased body temperature or blood flow differences
Convergence of elevated brain temperature with elevated lactate/creatine ratios in right insula, right thalamus, and cerebellum
Metabolite ratios in seven brain regions correlated with fatigue severity (p < 0.05)
Wide distribution of metabolite abnormalities across 47 brain regions examined
Inferred Conclusions
ME/CFS involves widespread metabolite abnormalities consistent with neuroinflammation
Elevated brain temperature and lactate in multiple regions suggests abnormal energy metabolism and inflammatory processes in the brain
The pattern of metabolite changes across distributed brain regions indicates a systemic rather than localized brain abnormality
Neurochemical abnormalities may mechanistically contribute to fatigue and other ME/CFS symptoms
Remaining Questions
Do these metabolite abnormalities normalize with treatment, and if so, do they correlate with symptom improvement?
What This Study Does Not Prove
This study does not prove that neuroinflammation causes ME/CFS—it only shows associations between brain chemistry changes and the disease. It cannot establish whether these metabolic abnormalities are primary contributors to symptoms or secondary consequences of the illness. The small sample size and cross-sectional design limit generalizability and prevent causal inference.